Establishment of a LVAD Destination Program in a Swiss Non Cardiac Transplant University Hospital

NCT04263012 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-02-20

No results posted yet for this study

Summary

The goal of this study is to demonstrate the challenges and the effort to set up an artificial heart program as well as to report about the follow-up treatment and the mortality rate

Conditions

  • Heart Implant Complication

Interventions

OTHER

collection of patient data

assess mortality rate, rehospitalization and survival rate of patients after receiving an artificial heart implant

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Martin Grapow, Prof Dr. med. · Herzzentrum Hirslanden Zürich

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04263012 on ClinicalTrials.gov